Home › Breast Cancer › NCT06603597
HER2-positive Breast Cancer Registry
RecruitingObservational study
Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Stage I-IV HER2-positive breast cancer Exclusion Criteria: * None
About the study
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Sponsor: Priyanka Sharma · Participants: 1,000 · Started: Sep 27, 2024
Contact the study team
- Study Coordinator · Phone: 913-588-6079
Official record on ClinicalTrials.gov — NCT06603597
Locations in the U.S.
| Kansas | The University of Kansas Cancer Center, Westwood |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.